Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The AAPS Journal|June 6, 2024
Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the ApproachJohn P Prybylski, Yuchen Wang, Vaishali Sahasrabudhe, et al.
The AAPS Journal|January 22, 2025
Operating Characteristics of the Simulated Healthy Participant Approach in Impaired Clearance StudiesSana Gupta, Vivek Purohit, Yuchen Wang, et al.
Journal of Clinical Pharmacology|May 21, 2020
Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression AnalysisVivek Purohit, Steve Riley, Huaming Tan, et al.
Journal of Pharmaceutical Sciences|July 30, 2005
Aggregation kinetics of recombinant human FVIII (rFVIII)Karthik Ramani, Vivek Purohit, C Russell Middaugh, et al.
Journal of Drugs in Dermatology : JDD|February 28, 2019
Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label StudyPhoebe Rich, Mary Spellman, Vivek Purohit, et al.
The AAPS Journal|June 5, 2026
Quantitative Estimation of Clinical Intrasubject Variability of a Pharmacokinetic ParameterHao-Jui Hsu, Katrina Casteel, Samuel Yang, et al.
The AAPS Journal|January 24, 2024
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic ModelAnas Saadeddin, Vivek Purohit, Yeamin Huh, et al.
Journal of Pharmaceutical Sciences|February 27, 2008
Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia AKarthik Ramani, Vivek Purohit, Razvan Miclea, et al.
The AAPS Journal|March 28, 2023
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib PharmacokineticsVivek Purohit, Yeamin Huh, Jessica Wojciechowski, et al.
The AAPS Journal|April 1, 2025
Virtual Bioequivalence Assessment of Tofacitinib Once Daily Modified Release Dosage Form in Pediatric SubjectsKazuko Sagawa, Vivek Purohit, Vu Le, et al.
Pageof 3